
News|Slideshows|June 17, 2026
Research Highlights from SNMMI 2026
Author(s)Diagnostic Imaging Staff
Catch up on the latest imaging research from the recent SNMMI conference.
Advertisement
Take a look back at some of the most viewed research updates from the annual SNMMI conference. Topics ranged from preliminary findings with the alpha-emitting radioconjugate ATNM-400 for prostate cancer and the combination of CT attenuation correction mapping and AI for coronary artery calcium (CAC) risk stratification to significant upstaging with PSMA PET/CT in patients with osseous oligometastatic PCa. Review the slideshow below to see highlighted research updates from the recent SNMMI conference.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Molecular Imaging in Focus: Key Takeaways from the 2026 SNMMI Conference with Michael Hofman, MBBS, FRACP
2
Five Strategies to Facilitate Technology Implementation and Alleviate Radiologist Turnover
3
FDA Approves Low-Dose MRI Contrast Agent Gadoquatrane
4
Can Breast Ultrasound AI Offer Comparable Sensitivity to Radiologists in Pregnant and Lactating Women?
5














